BMS says spend increased by 23% in Q3

Share this content:
Bristol-Myers Squibb said its advertising and promotional spend increased by 23% in the third quarter, in part due to increased DTC advertising of Plavix and Abilify.
Share this content:
Scroll down to see the next article